What Breakthru Psychiatric Solutions does

Breakthru Psychiatric Solutions is a private interventional psychiatry practice founded in 2020 during the COVID pandemic by psychiatrist Dr. Karen Giles, MD and business leader Jim Benjamin, operating under the legal entity Slick Innovations, LLC. The practice operates clinics in Sandy Springs and Alpharetta, Georgia, with a third location in Tucker, GA scheduled to open in July 2026. It serves patients with treatment-resistant mental health conditions — primarily major depressive disorder, anxiety disorders, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD) — who have not responded adequately to traditional antidepressant medications and psychotherapy. Patient volume is generated through a direct-to-consumer model supplemented by healthcare provider referrals, with no enterprise or institutional customers.

The practice's treatment portfolio centers on interventional psychiatric modalities delivered under physician supervision. Core offerings include Transcranial Magnetic Stimulation (TMS) in multiple protocol variants — a standard 9-week protocol, Accelerated TMS (40 iTBS sessions over two weeks), the proprietary ONE-D TMS (20 sessions in a single day combined with Vyvanse and D-cycloserine), AMPLIFI TMS for OCD (targeting DMPFC and rOFC), and MagVenture adolescent TMS for patients ages 15-21. Additional modalities include Spravato (esketamine nasal spray, FDA-approved for treatment-resistant depression), IV Ketamine infusions, Prism for PTSD (an FDA-cleared EEG-based neurofeedback device sourced via a partnership with GrayMatters Health), and Vagus Nerve Stimulation. Breakthru positions itself as the first provider in Georgia to offer ONE-D TMS, and reports clinical outcome figures across modalities, including 93.9% depression improvement with TMS, 95.8% with IV Ketamine, 89.7% with Spravato, and 67% clinically significant symptom improvement with Prism.

Revenue is generated through a dual insurance/self-pay billing model. Traditional TMS, Spravato, and VNS are billed through insurance (Aetna, Anthem Blue Cross Blue Shield, Cigna, Humana, and United Health Care) with prior authorization, while IV Ketamine, Accelerated TMS, ONE-D TMS, and Prism for PTSD are self-pay only. The practice is bootstrapped with no disclosed external funding rounds, operates with a 1–10 employee footprint including a five-person physician team, and does not publicly disclose revenue.

Name

Breakthru Psychiatric Solutions

Legal name

Slick Innovations, LLC

Website

https://breakthrupsych.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Breakthru Psychiatric Solutions is a private interventional psychiatry practice in Georgia providing TMS, Spravato, IV Ketamine, Prism for PTSD, and VNS treatments to patients with treatment-resistant depression, anxiety, PTSD, and OCD.

Ownership category

akta.pro rank

Product category

Interventional Psychiatry Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Other Ambulatory Health Care Services (6219)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Behavioral Health for Children & Adolescents (Youth Services) (HLAFACAL)

Keywords

• Interventional psychiatry
• Transcranial magnetic stimulation
• Treatment-resistant depression
• Esketamine nasal spray
• IV ketamine therapy

Headquarters

HQ city

Sandy Springs

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Treatment Services: Revenue generated from providing interventional psychiatric treatments including TMS, Spravato, IV Ketamine, Prism, and VNS. Services are billed through insurance for covered treatments or collected as self-pay for non-covered treatments. Insurance accepted includes Aetna, Anthem Blue Cross Blue Shield, Cigna, Humana, and United Health Care.
2. Insurance Reimbursements: Traditional TMS, Spravato, and VNS Therapy are covered by many insurance plans. These treatments require prior authorization and are billed through the patient's insurance provider.
3. Self-Pay Services: IV Ketamine, Accelerated TMS, ONE-D TMS, and Prism for PTSD are not covered by insurance and are collected as self-pay from patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Breakthru Psychiatric Solutions provides interventional psychiatric treatments for patients with treatment-resistant mental health conditions (depression, anxiety, PTSD, OCD). The practice administers Transcranial Magnetic Stimulation (TMS) with multiple protocols including ONE-D TMS, Accelerated TMS, AMPLIFI TMS for OCD, and TMS for Adolescents; Spravato (esketamine nasal spray); IV Ketamine infusions; Prism for PTSD neurofeedback; and Vagus Nerve Stimulation (VNS) Therapy. Treatments are delivered under psychiatrist supervision at clinic locations in the Atlanta, Georgia metropolitan area.

Product overview

Breakthru Psychiatric Solutions offers interventional psychiatric treatments for treatment-resistant mental health conditions. The core offerings include three main treatment modalities: Transcranial Magnetic Stimulation (TMS) with multiple protocol variants (Standard TMS, Accelerated TMS, ONE-D TMS, AMPLIFI TMS for OCD, and TMS for Adolescents), Spravato (esketamine nasal spray), and IV Ketamine infusions. Additional treatments include Prism for PTSD (neurofeedback therapy) and Vagus Nerve Stimulation (implanted device). These treatments are offered as alternatives or complements to traditional medication management for patients who have not responded to conventional antidepressant therapies.

Differentiator

Problem solved

Functional benefit

Products and services

• Transcranial Magnetic Stimulation (TMS)

Quantifiable outcome

• 93.9% depression improvement, 87.9% anxiety improvement, 42.4% remission rates with TMS
• +4 more outcomes

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• GrayMatters HealthcoreTechnology or Integration · 30 October 2024GrayMatters Health is the manufacturer of Prism for PTSD, an FDA-cleared neurofeedback treatment. Breakthru offers Prism as one of their treatment options for PTSD patients. The news indicates expansion of Prism access across multiple clinics including Georgia locations. Clinical trial data published in the Journal of Psychiatry Research demonstrated 67% clinically significant symptom improvement rate among patients using the device.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Cerebral: Digital mental health platform offering medication management and therapy for depression and anxiety. Adjacent mental health space but different delivery model (telehealth) and focuses on pharmaceutical rather than interventional approaches, serving some overlapping patient needs.
• Amen Clinics: Established brain health clinic chain offering SPECT imaging and psychiatric evaluation services. Overlapping patient demographic in treatment-resistant mental health but different clinical approach focused on brain imaging diagnostics rather than interventional procedures.
• Mindpath Health: Larger psychiatric services platform offering comprehensive mental health care including therapy, medication management, and interventional treatments. Overlapping patient base in treatment-resistant mental health but broader service portfolio and significantly larger operational scale than Breakthru's specialty focus.

Direct peers

• Greenbrook TMS: Major North American network of TMS treatment centers offering similar outpatient interventional psychiatry services for treatment-resistant depression. Directly comparable specialty clinic model serving similar patient populations with TMS-focused treatment protocols and physician-supervised delivery.

Others

• Talkspace: Online therapy platform connecting patients with licensed therapists via text, audio, and video messaging. Different delivery model and treatment approach (talk therapy vs. interventional psychiatry), but serves similar mental health patient population through employer benefits and direct-to-consumer channels.
• Neuronetics: Manufacturer of the NeuroStar TMS system, a widely-used platform in interventional psychiatry clinics including adolescent applications. Industry supplier and category enabler rather than direct competitor to Breakthru's clinical operations, but a key dependency for any TMS-focused practice.
• BrainsWay: Manufacturer of Deep TMS systems used by interventional psychiatry clinics across the US. Industry supplier and category enabler rather than direct competitor, but the company's commercial success reflects and supports demand for TMS-based treatment models similar to Breakthru's.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/breakthru-psychiatric-solutions-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Breakthru Psychiatric Solutions